Reported purity99.721%
Task number#150653
Tested21 APR 2026
VerificationReport available
About TB-500
99.721% purity — independently analysed
Sulan Bio TB-500 batch SUL0330-001 was independently analysed by Janoshik Laboratory under task #150653.
The analytical report recorded 99.721% purity and 11.30mg measured content for the submitted 10mg sample, providing batch-specific analytical documentation for this marketplace listing.
What is TB-500?
TB-500 is a research peptide associated with thymosin beta-4 (Tβ4), a naturally occurring peptide involved in a variety of cellular processes and particularly known for its relationship with actin regulation.
Thymosin beta-4 interacts with actin, an important structural protein involved in cell shape, movement and cytoskeletal organisation. This relationship has made TB-500 and thymosin beta-4 pathways subjects of research involving cell migration, tissue remodelling and cellular repair mechanisms.
Common research areas
TB-500 and thymosin beta-4-related pathways are commonly investigated in laboratory and cellular research examining:
- Actin binding and cytoskeletal regulation
- Cell migration and cellular motility
- Tissue-remodelling pathways
- Cellular repair and regeneration signalling
- Angiogenesis and vascular signalling
- Fibroblast and connective-tissue biology
- Cell survival and stress-response pathways
- Inflammatory signalling in experimental models
TB-500 and thymosin beta-4 research
TB-500 is commonly discussed in relation to thymosin beta-4 research. Tβ4 is a naturally occurring peptide with an established role in actin sequestration and cytoskeletal organisation.
These properties make thymosin beta-4-related peptides relevant to experimental studies examining how cells migrate, reorganise their cytoskeleton and participate in tissue-remodelling processes.
Available configurations
- 5mg: 10 vials per box
- 10mg: 10 vials per box
- MOQ: 10 vials / 1 box
- Format: Lyophilized research peptide
- Supplier: Sulan Bio
Batch verification
- Supplier: Sulan Bio
- Batch: SUL0330-001
- Reported purity: 99.721%
- Measured content: 11.30mg
- Tested strength: 10mg
- Independent laboratory: Janoshik
- Task number: #150653
- Tested: 21 APR 2026
- COA status: Available
This product is supplied strictly for laboratory research and analytical applications. It is not intended for human consumption, medical use, diagnostic use or clinical application.
Purity99.721%
Format5MG~10MG
MOQ10 vials / 1 box
Ships fromChina
Laboratory report
This listing is provided for laboratory and research sourcing review. It is not intended for human consumption, medical use or self-administration.